A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1
- Resource Type
- Article
- Authors
- Gallage, Suchira; Ali, Adnan; Barragan Avila, Jose Efren; Seymen, Nogayhan; Ramadori, Pierluigi; Joerke, Vera; Zizmare, Laimdota; Aicher, David; Gopalsamy, Indresh K.; Fong, Winnie; Kosla, Jan; Focaccia, Enrico; Li, Xin; Yousuf, Suhail; Sijmonsma, Tjeerd; Rahbari, Mohammad; Kommoss, Katharina S.; Billeter, Adrian; Prokosch, Sandra; Rothermel, Ulrike; Mueller, Florian; Hetzer, Jenny; Heide, Danijela; Schinkel, Benjamin; Machauer, Tim; Pichler, Bernd; Malek, Nisar P.; Longerich, Thomas; Roth, Susanne; Rose, Adam J.; Schwenck, Johannes; Trautwein, Christoph; Karimi, Mohammad M.; Heikenwalder, Mathias
- Source
- In Cell Metabolism 4 June 2024 36(6):1371-1393
- Subject
- Language
- ISSN
- 1550-4131